Using advanced MRI to detect brain diseases
Brain Diseases on 7.0T Magnetic Resonance Imaging
This study tests if a stronger 7-Tesla MRI can find brain diseases like tumors better than the regular 3-Tesla MRI for people who might have these conditions.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Chinese PLA General Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT05287750 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of 7-Tesla (7T) magnetic resonance imaging (MRI) compared to standard 3T MRI in identifying brain diseases such as tumors and cerebrovascular conditions. The study focuses on the enhanced sensitivity and resolution of 7T MRI, which may lead to better diagnostic accuracy and treatment decisions. Participants will undergo MRI scans to evaluate the imaging characteristics and diagnostic capabilities of 7T MRI in clinical settings.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 80 who have been diagnosed with brain diseases and are clinically stable.
Not a fit: Patients under 18 or over 80, pregnant individuals, or those with contraindications to MRI will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnoses and improved treatment strategies for patients with brain diseases.
How similar studies have performed: Other studies have shown promising results with advanced MRI techniques, suggesting that this approach may enhance diagnostic capabilities.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age≥18 and ≤80 * Having brain diseases (eg: brain tumor, cerebrovascular diseases) * Having no contraindications against MRI or intravenous contrast agent administration * Clinically stable Exclusion Criteria: * Age\<18 or \>80 * Pregnancy and other contraindication to MRI scan * Informed consent not obtained
Where this trial is running
Beijing
- Chinese PLA General Hospital — Beijing, China (Recruiting)
Study contacts
- Study coordinator: Kun Cheng, M.S.
- Email: dr_chengkun@163.com
- Phone: +86 19921784434
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.